Publication | Open Access
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia
184
Citations
9
References
2019
Year
ClinicalTrials.gov identifier: NCT02586025.
| Year | Citations | |
|---|---|---|
Page 1
Page 1